| Product Code: ETC9949163 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Monkeypox Vaccine and Treatment Market - Industry Life Cycle |
3.4 United Kingdom (UK) Monkeypox Vaccine and Treatment Market - Porter's Five Forces |
3.5 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about monkeypox and its potential threats |
4.2.2 Government initiatives to combat infectious diseases |
4.2.3 Technological advancements in vaccine development and treatment options |
4.3 Market Restraints |
4.3.1 Limited availability of monkeypox vaccines and treatment options |
4.3.2 High costs associated with vaccine production and distribution |
4.3.3 Regulatory challenges in vaccine approval and market entry |
5 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Trends |
6 United Kingdom (UK) Monkeypox Vaccine and Treatment Market, By Types |
6.1 United Kingdom (UK) Monkeypox Vaccine and Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.1.4 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.5 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Vaccinia Immune Globulin (VIG), 2021- 2031F |
6.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3 United Kingdom (UK) Monkeypox Vaccine and Treatment Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Export to Major Countries |
7.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Imports from Major Countries |
8 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Key Performance Indicators |
8.1 Number of reported monkeypox cases in the UK |
8.2 Funding allocated for research and development of monkeypox vaccines |
8.3 Adoption rate of monkeypox vaccination programs among at-risk populations |
9 United Kingdom (UK) Monkeypox Vaccine and Treatment Market - Opportunity Assessment |
9.1 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United Kingdom (UK) Monkeypox Vaccine and Treatment Market - Competitive Landscape |
10.1 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Monkeypox Vaccine and Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here